insights_auto
Why is TWST up 5,52%?
Dive Deeperchevron_right
TWST:NASDAQ
Twist Bioscience Corp
147,49 $
arrow_upward
+5,52%(+7,72) 1D
20 қаз., 14:32:45 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
139,77 $
High
148,83 $
Low
134,94 $
Mkt. cap
9,80 млрд
Avg. vol.
2,84 млн
Volume
1,33 млн
52-wk high
219,71 $
52-wk low
23,30 $
EPS
-2,22 $
Beta
2,19
Shares outstanding
65,83 млн
No. of employees
979
Open
139,77 $
High
148,83 $
Low
134,94 $
Mkt. cap
9,80 млрд
Avg. vol.
2,84 млн
Volume
1,33 млн
52-wk high
219,71 $
52-wk low
23,30 $
EPS
-2,22 $
Beta
2,19
Shares outstanding
65,83 млн
No. of employees
979
News stories
From web sources and news partners
ad-hoc-news.de
·
6 сағат бұрын
TD Cowen lifts target to USD 190 for Twist Bioscience stock
Simply Wall Street
·
10 сағат бұрын
Is Twist Bioscience (TWST) Too Rich Or Still Reasonable On Sales?
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp